Explore innovative therapies for neonatal hypoxic-ischemic encephalopathy, focusing on neuroprotection and challenges in ...

Hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of newborn mortality and morbidity worldwide, and lowering ...

Hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of newborn mortality and morbidity worldwide, and lowering the baby’s body temperature—called therapeutic hypothermia—is often used ...

Hypoxic stress usually results a tubulo-interstitial damage in newborns. One of the sensitive biomarker of proximal tubular impairments is a kidney injure molecule-1(KIM-1). KIM-1 is a ...

Hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of newborn mortality and morbidity worldwide, and lowering the baby's body ...

Objective: To determine whether Phenobarbital (PB) given before therapeutic hypothermia to infants with hypoxic-ischemic encephalopathy (HIE) augments the neuroprotective efficacy of hypothermia.

Baby Ella became the first newborn in the Cayman Islands to receive full therapeutic hypothermia treatment for hypoxic ...

Objective: To determine the impact of the establishment of a Neonatal Extracorporeal Membrane Oxygenation Program on the outcome of newborns with severe hypoxic respiratory failure in a developing ...

The drug candidate treats hypoxic ischaemic encephalopathy (HIE), a condition in which a baby’s brain is injured through a ...